Literature DB >> 24356086

Dissemination, analysis, and implementation of the World Report on Disability: the roadmap of the International Society for Physical and Rehabilitation Medicine.

Christoph Gutenbrunner1, Matthias Bethge, Gerold Stucki, Jianan Li, Jorge Lains, John Olver, Walter Frontera, Per von Groote, Alessandro Giustini, Marta Imamura.   

Abstract

The International Society for Physical and Rehabilitation Medicine has recognized the World Report on Disability as a guide for its future activities and endorsed its responsibility to disseminate, to analyze, and to implement the report's recommendations. The activities of the International Society for Physical and Rehabilitation Medicine on the global stage are embedded in a strategy that includes national and regional associations. This article reports on recent and forthcoming activities of the International Society for Physical and Rehabilitation Medicine regarding the World Report on Disability and identifies five major challenges that will impact future International Society for Physical and Rehabilitation Medicine activities. These challenges relate to (1) education and training, (2) the support of strong role models, (3) disaster management, (4) the development of innovative rehabilitation services, and (5) rehabilitation research.

Mesh:

Year:  2014        PMID: 24356086     DOI: 10.1097/PHM.0000000000000026

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  2 in total

1.  An innovative case management intervention for people at high risk of permanent work disability to improve rehabilitation coverage and coordination of health services: a randomized controlled trial (AktiFAME, DRKS00024648).

Authors:  Lea Remus; Marei Grope; Stella Lemke; Matthias Bethge
Journal:  BMC Health Serv Res       Date:  2022-03-15       Impact factor: 2.655

2.  A comprehensive diagnostic service to clarify intervention needs when work participation is at risk: study protocol of a randomized controlled trial (GIBI, DRKS00027577).

Authors:  David Fauser; Saskia Dötsch; Claudia Langer; Vera Kleineke; Claudia Kindel; Matthias Bethge
Journal:  BMC Health Serv Res       Date:  2022-09-09       Impact factor: 2.908

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.